Metagenomi, Inc. Common Stock ( MGX) - Key Metrics
MGX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | -$0.01 | -$0.73 | -$0.52 | -$0.52 |
| 2026Q1 | $0.03 | -$0.61 | -$0.56 | -$0.56 |
| 2025Q4 | $0.10 | -$0.60 | -$0.63 | -$0.63 |
| 2025Q3 | $0.23 | -$0.55 | -$0.57 | -$0.57 |
| 2025Q2 | $0.23 | -$0.54 | -$0.57 | -$0.58 |
MGX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.41 |
| 2026Q1 | 0% | -0.55 |
| 2025Q4 | 0% | -0.68 |
| 2025Q3 | 0% | -1.08 |
| 2025Q2 | 0% | -0.69 |
MGX
Price: $1.23
52 week price:
Earnings Per Share: -2.55 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 46.5 million